Ultragenyx Pharmaceutical Inc. (RARE)
USD 34.92
(2.28%)
USD 34.92
(2.28%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -606.63 Million USD | 14.25% |
| 2022 | -707.42 Million USD | -55.81% |
| 2021 | -454.02 Million USD | -143.36% |
| 2020 | -186.56 Million USD | 53.67% |
| 2019 | -402.72 Million USD | -103.8% |
| 2018 | -197.61 Million USD | 34.6% |
| 2017 | -302.13 Million USD | -22.88% |
| 2016 | -245.87 Million USD | -68.85% |
| 2015 | -145.61 Million USD | -143.5% |
| 2014 | -59.8 Million USD | -70.52% |
| 2013 | -35.07 Million USD | -114.71% |
| 2012 | -16.33 Million USD | -138.49% |
| 2011 | -6.84 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -131.59 Million USD | 22.9% |
| 2024 Q1 | -170.68 Million USD | -38.55% |
| 2023 FY | -606.63 Million USD | 14.25% |
| 2023 Q3 | -159.64 Million USD | 0.11% |
| 2023 Q1 | -163.97 Million USD | -7.99% |
| 2023 Q2 | -159.82 Million USD | 2.53% |
| 2023 Q4 | -123.19 Million USD | 22.84% |
| 2022 Q3 | -245.1 Million USD | -54.97% |
| 2022 Q4 | -151.83 Million USD | 38.05% |
| 2022 FY | -707.42 Million USD | -55.81% |
| 2022 Q1 | -152.32 Million USD | -24.39% |
| 2022 Q2 | -158.16 Million USD | -3.84% |
| 2021 Q4 | -122.45 Million USD | -67.76% |
| 2021 FY | -454.02 Million USD | -143.36% |
| 2021 Q1 | -136.14 Million USD | -466.99% |
| 2021 Q2 | -122.42 Million USD | 10.07% |
| 2021 Q3 | -72.99 Million USD | 40.37% |
| 2020 Q2 | 25.31 Million USD | 121.27% |
| 2020 Q4 | -24.01 Million USD | 65.12% |
| 2020 Q1 | -119.02 Million USD | -26.89% |
| 2020 FY | -186.56 Million USD | 53.67% |
| 2020 Q3 | -68.84 Million USD | -371.95% |
| 2019 Q2 | -99.17 Million USD | -2.5% |
| 2019 FY | -402.72 Million USD | -103.8% |
| 2019 Q1 | -96.75 Million USD | -10.17% |
| 2019 Q4 | -93.8 Million USD | 16.98% |
| 2019 Q3 | -112.99 Million USD | -13.94% |
| 2018 Q3 | -87.31 Million USD | -65.59% |
| 2018 FY | -197.61 Million USD | 34.6% |
| 2018 Q1 | 30.25 Million USD | 137.02% |
| 2018 Q2 | -52.72 Million USD | -274.29% |
| 2018 Q4 | -87.82 Million USD | -0.59% |
| 2017 FY | -302.13 Million USD | -22.88% |
| 2017 Q1 | -68.29 Million USD | 4.2% |
| 2017 Q2 | -72.89 Million USD | -6.74% |
| 2017 Q3 | -79.22 Million USD | -8.69% |
| 2017 Q4 | -81.73 Million USD | -3.16% |
| 2016 Q1 | -52.75 Million USD | 4.46% |
| 2016 Q4 | -71.28 Million USD | -9.83% |
| 2016 Q3 | -64.9 Million USD | -14.03% |
| 2016 Q2 | -56.92 Million USD | -7.9% |
| 2016 FY | -245.87 Million USD | -68.85% |
| 2015 Q3 | -39.23 Million USD | -31.71% |
| 2015 Q2 | -29.78 Million USD | -39.33% |
| 2015 Q1 | -21.37 Million USD | -27.73% |
| 2015 FY | -145.61 Million USD | -143.5% |
| 2015 Q4 | -55.22 Million USD | -40.75% |
| 2014 Q1 | -13.63 Million USD | -20.44% |
| 2014 Q4 | -16.73 Million USD | -5.61% |
| 2014 Q3 | -15.84 Million USD | -16.67% |
| 2014 Q2 | -13.58 Million USD | 0.33% |
| 2014 FY | -59.8 Million USD | -70.52% |
| 2013 Q1 | -6.73 Million USD | -36.61% |
| 2013 Q3 | -8.42 Million USD | 1.89% |
| 2013 Q4 | -11.31 Million USD | -34.28% |
| 2013 FY | -35.07 Million USD | -114.71% |
| 2013 Q2 | -8.59 Million USD | -27.54% |
| 2012 Q4 | -4.93 Million USD | 0.0% |
| 2012 FY | -16.33 Million USD | -138.49% |
| 2011 FY | -6.84 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Agenus Inc. | -245.76 Million USD | -146.841% |
| Immix Biopharma, Inc. | -15.42 Million USD | -3832.563% |
| Keros Therapeutics, Inc. | -152.99 Million USD | -296.517% |
| Caribou Biosciences, Inc. | -102.07 Million USD | -494.336% |
| Madrigal Pharmaceuticals, Inc. | -373.63 Million USD | -62.364% |
| MiMedx Group, Inc. | 67.43 Million USD | 999.537% |
| Novavax, Inc. | -545.06 Million USD | -11.297% |
| Seer, Inc. | -86.27 Million USD | -603.129% |
| Acelyrin, Inc. | -381.64 Million USD | -58.955% |
| Xeris Biopharma Holdings, Inc. | -62.25 Million USD | -874.442% |
| IO Biotech, Inc. | -86.08 Million USD | -604.714% |
| Ardelyx, Inc. | -66.06 Million USD | -818.218% |
| C4 Therapeutics, Inc. | -132.49 Million USD | -357.865% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.6 Million USD | -1260.076% |
| Fortress Biotech, Inc. | -60.63 Million USD | -900.444% |
| Fortress Biotech, Inc. | -60.63 Million USD | -900.444% |
| Geron Corporation | -184.12 Million USD | -229.468% |
| Arrowhead Pharmaceuticals, Inc. | -205.27 Million USD | -195.525% |
| HOOKIPA Pharma Inc. | -81.58 Million USD | -643.612% |
| Incyte Corporation | 597.59 Million USD | 201.513% |
| Innoviva, Inc. | 179.72 Million USD | 437.543% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -7036.09% |
| ChromaDex Corporation | -4.93 Million USD | -12185.115% |
| Ligand Pharmaceuticals Incorporated | 52.15 Million USD | 1263.169% |
| MEI Pharma, Inc. | 17.77 Million USD | 3512.302% |
| NextCure, Inc. | -62.72 Million USD | -867.172% |
| Onconetix, Inc. | -37.4 Million USD | -1521.609% |
| Oncternal Therapeutics, Inc. | -39.47 Million USD | -1436.612% |
| GlycoMimetics, Inc. | -36.89 Million USD | -1544.034% |
| IDEAYA Biosciences, Inc. | -112.96 Million USD | -437.034% |
| Vaxcyte, Inc. | -402.26 Million USD | -50.805% |
| Precigen, Inc. | -95.9 Million USD | -532.548% |
| Pharming Group N.V. | -10.54 Million USD | -5651.223% |
| ContextLogic Inc. | -317 Million USD | -91.369% |
| TRACON Pharmaceuticals, Inc. | -3.58 Million USD | -16807.441% |
| Pyxis Oncology, Inc. | -73.79 Million USD | -722.115% |
| Rigel Pharmaceuticals, Inc. | -25.09 Million USD | -2317.755% |
| AlloVir, Inc. | -190.41 Million USD | -218.583% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -2392.427% |
| Marinus Pharmaceuticals, Inc. | -141.4 Million USD | -329.008% |
| Salarius Pharmaceuticals, Inc. | -12.54 Thousand USD | -4836494.064% |
| Summit Therapeutics Inc. | -614.92 Million USD | 1.348% |
| Syndax Pharmaceuticals, Inc. | -209.36 Million USD | -189.759% |
| Sensei Biotherapeutics, Inc. | -34.1 Million USD | -1678.948% |
| Senti Biosciences, Inc. | -92.91 Million USD | -552.869% |
| BioXcel Therapeutics, Inc. | -179.05 Million USD | -238.804% |
| Alaunos Therapeutics, Inc. | -35.14 Million USD | -1626.349% |
| Entrada Therapeutics, Inc. | -6.68 Million USD | -8974.63% |
| Psyence Biomedical Ltd. | -51.15 Million USD | -1085.79% |
| Outlook Therapeutics, Inc. | -58.98 Million USD | -928.504% |
| Chimerix, Inc. | -82.09 Million USD | -638.948% |
| PDS Biotechnology Corporation | -42.94 Million USD | -1312.687% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | -2889.695% |
| CRISPR Therapeutics AG | -153.61 Million USD | -294.922% |
| Wave Life Sciences Ltd. | -57.51 Million USD | -954.786% |
| Phathom Pharmaceuticals, Inc. | -201.59 Million USD | -200.924% |
| Pieris Pharmaceuticals, Inc. | -24.54 Million USD | -2371.739% |
| CARGO Therapeutics, Inc. Common Stock | -98.14 Million USD | -518.092% |
| Precision BioSciences, Inc. | -61.31 Million USD | -889.317% |
| Dyadic International, Inc. | -6.79 Million USD | -8827.121% |
| Elevation Oncology, Inc. | -45.7 Million USD | -1227.321% |
| Eton Pharmaceuticals, Inc. | -936 Thousand USD | -64711.859% |
| Akebia Therapeutics, Inc. | -51.92 Million USD | -1068.299% |
| Alnylam Pharmaceuticals, Inc. | -440.24 Million USD | -37.797% |
| Aptorum Group Limited | -2.82 Million USD | -21376.631% |
| Bicycle Therapeutics plc | -180.66 Million USD | -235.783% |
| Telomir Pharmaceuticals, Inc. Common Stock | -13.07 Million USD | -4540.8% |
| Clearside Biomedical, Inc. | -32.48 Million USD | -1767.443% |
| Inhibikase Therapeutics, Inc. | -19.02 Million USD | -3087.991% |
| GT Biopharma, Inc. | -7.59 Million USD | -7885.244% |
| Alkermes plc | 355.75 Million USD | 270.521% |
| Verrica Pharmaceuticals Inc. | -66.99 Million USD | -805.499% |
| Jaguar Health, Inc. | -41.3 Million USD | -1368.86% |
| VistaGen Therapeutics, Inc. | -29.36 Million USD | -1966.068% |
| AbCellera Biologics Inc. | -146.39 Million USD | -314.377% |
| PureTech Health plc | -65.69 Million USD | -823.389% |
| TransCode Therapeutics, Inc. | -18.54 Million USD | -3170.98% |
| Sangamo Therapeutics, Inc. | -257.83 Million USD | -135.286% |
| SELLAS Life Sciences Group, Inc. | -37.34 Million USD | -1524.636% |
| Barinthus Biotherapeutics plc | -73.34 Million USD | -727.081% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -2392.427% |
| Aadi Bioscience, Inc. | -65.76 Million USD | -822.434% |
| AnaptysBio, Inc. | -163.61 Million USD | -270.763% |
| eFFECTOR Therapeutics, Inc. | -35.81 Million USD | -1594.002% |
| ESSA Pharma Inc. | -26.58 Million USD | -2182.113% |
| Molecular Templates, Inc. | -8.12 Million USD | -7367.245% |
| Scopus BioPharma Inc. | -11.6 Million USD | -5125.22% |
| Sorrento Therapeutics, Inc. | -572.84 Million USD | -5.9% |
| Vaxxinity, Inc. | -56.93 Thousand USD | -1065412.699% |
| Viracta Therapeutics, Inc. | -51.05 Million USD | -1088.137% |
| Sol-Gel Technologies Ltd. | -27.23 Million USD | -2127.179% |
| Janux Therapeutics, Inc. | -58.29 Million USD | -940.672% |
| Structure Therapeutics Inc. | -89.62 Million USD | -576.901% |
| Longboard Pharmaceuticals, Inc. | -54.42 Million USD | -1014.694% |
| Stoke Therapeutics, Inc. | -104.69 Million USD | -479.412% |
| ImmuCell Corporation | -5.77 Million USD | -10405.303% |
| Lantern Pharma Inc. | -15.96 Million USD | -3700.631% |
| VYNE Therapeutics Inc. | -28.45 Million USD | -2032.149% |
| Ocuphire Pharma, Inc. | -9.98 Million USD | -5974.895% |
| Opthea Limited | -220.24 Million USD | -175.442% |
| Avidity Biosciences, Inc. | -212.22 Million USD | -185.854% |
| Syros Pharmaceuticals, Inc. | -164.57 Million USD | -268.612% |
| Fate Therapeutics, Inc. | -160.92 Million USD | -276.963% |
| Inhibrx Biosciences, Inc. | -241.36 Million USD | -151.341% |
| Catalyst Pharmaceuticals, Inc. | 71.41 Million USD | 949.515% |
| Orchestra BioMed Holdings, Inc. | -49.12 Million USD | -1135.014% |
| Alzamend Neuro, Inc. | -9.94 Million USD | -5998.256% |
| Rocket Pharmaceuticals, Inc. | -245.59 Million USD | -147.008% |
| Aptose Biosciences Inc. | -51.2 Million USD | -1084.68% |
| ZyVersa Therapeutics, Inc. | -98.29 Million USD | -517.143% |
| Soligenix, Inc. | -6.14 Million USD | -9778.939% |
| Century Therapeutics, Inc. | -136.67 Million USD | -343.862% |
| Kura Oncology, Inc. | -152.63 Million USD | -297.455% |
| TScan Therapeutics, Inc. | -89.21 Million USD | -579.951% |
| Intensity Therapeutics, Inc. | -10.53 Million USD | -5656.681% |
| Ocean Biomedical, Inc. | 565.47 Thousand USD | 107380.492% |
| CytomX Therapeutics, Inc. | -569 Thousand USD | -106514.938% |
| Autolus Therapeutics plc | -208.38 Million USD | -191.117% |
| Mineralys Therapeutics, Inc. | -71.89 Million USD | -743.749% |
| EyePoint Pharmaceuticals, Inc. | -70.79 Million USD | -756.895% |
| Eterna Therapeutics Inc. | -21.66 Million USD | -2699.7% |
| Adaptive Biotechnologies Corporation | -225.25 Million USD | -169.318% |
| GRI Bio, Inc. | -13.03 Million USD | -4553.21% |
| Xenetic Biosciences, Inc. | -4.13 Million USD | -14572.332% |
| Tenaya Therapeutics, Inc. | -124.08 Million USD | -388.894% |
| IGM Biosciences, Inc. | -246.41 Million USD | -146.185% |
| INmune Bio, Inc. | -30 Million USD | -1921.591% |
| Heron Therapeutics, Inc. | -110.55 Million USD | -448.702% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -1337.745% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -3700.601% |
| Entero Therapeutics, Inc. | -15.79 Million USD | -3740.707% |
| Milestone Pharmaceuticals Inc. | -59.68 Million USD | -916.401% |
| X4 Pharmaceuticals, Inc. | -101.16 Million USD | -499.641% |
| Atara Biotherapeutics, Inc. | -276.12 Million USD | -119.696% |
| Coherus BioSciences, Inc. | -237.89 Million USD | -155.006% |
| Verastem, Inc. | -87.36 Million USD | -594.357% |
| Abeona Therapeutics Inc. | -54.18 Million USD | -1019.508% |
| Pliant Therapeutics, Inc. | -161.33 Million USD | -276.01% |
| Tonix Pharmaceuticals Holding Corp. | -116.65 Million USD | -420.015% |
| Histogen Inc. | -10.62 Million USD | -5611.694% |
| Aprea Therapeutics, Inc. | -14.28 Million USD | -4146.163% |
| Surrozen, Inc. | -43.04 Million USD | -1309.412% |
| Organovo Holdings, Inc. | -14.67 Million USD | -4034.953% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -11825.212% |
| Ovid Therapeutics Inc. | -52.33 Million USD | -1059.058% |
| Panbela Therapeutics, Inc. | -25.26 Million USD | -2301.294% |
| CASI Pharmaceuticals, Inc. | -26.93 Million USD | -2151.982% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.35 Million USD | -7158.978% |
| Centessa Pharmaceuticals plc | -151.08 Million USD | -301.522% |
| Hepion Pharmaceuticals, Inc. | -48.92 Million USD | -1139.91% |
| Arcturus Therapeutics Holdings Inc. | -29.72 Million USD | -1940.838% |
| BioRestorative Therapies, Inc. | -10.41 Million USD | -5723.155% |
| Apollomics, Inc. | -172.6 Million USD | -251.469% |
| Amarin Corporation plc | -59.11 Million USD | -926.254% |
| Mesoblast Limited | -87.95 Million USD | -589.707% |
| Turnstone Biologics Corp. | -55.2 Million USD | -998.984% |
| Kymera Therapeutics, Inc. | -146.96 Million USD | -312.786% |
| Synaptogenix, Inc. | -6.03 Million USD | -9946.18% |
| Tiziana Life Sciences Ltd | -16.2 Million USD | -3642.837% |
| Aurinia Pharmaceuticals Inc. | -78.02 Million USD | -677.543% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -12560.822% |
| Monopar Therapeutics Inc. | -8.4 Million USD | -7120.005% |
| Exelixis, Inc. | 207.76 Million USD | 391.983% |
| Better Therapeutics, Inc. | -39.76 Million USD | -1425.752% |
| Nurix Therapeutics, Inc. | -143.94 Million USD | -321.429% |
| Apellis Pharmaceuticals, Inc. | -528.62 Million USD | -14.757% |
| NLS Pharmaceutics AG | -12.17 Million USD | -4883.877% |
| Dermata Therapeutics, Inc. | -7.79 Million USD | -7682.721% |
| Aridis Pharmaceuticals, Inc. | -30.74 Million USD | -1872.874% |
| Gritstone bio, Inc. | -138.49 Million USD | -338.038% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -841.036% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | -15066.165% |
| Avid Bioservices, Inc. | -140.75 Million USD | -330.995% |
| Insmed Incorporated | -749.56 Million USD | 19.068% |
| Virpax Pharmaceuticals, Inc. | -15.18 Million USD | -3893.803% |
| MediWound Ltd. | -6.71 Million USD | -8932.743% |
| OmniAb, Inc. | -50.61 Million USD | -1098.441% |
| Alector, Inc. | -130.39 Million USD | -365.246% |
| Seres Therapeutics, Inc. | -113.72 Million USD | -433.431% |
| Checkpoint Therapeutics, Inc. | -51.84 Million USD | -1070.056% |
| Zai Lab Limited | -334.62 Million USD | -81.292% |
| Revance Therapeutics, Inc. | -323.98 Million USD | -87.242% |
| Aura Biosciences, Inc. | -76.4 Million USD | -693.947% |
| Lyell Immunopharma, Inc. | -234.63 Million USD | -158.549% |
| Immunic, Inc. | -93.61 Million USD | -548.036% |
| Tarsus Pharmaceuticals, Inc. | -135.89 Million USD | -346.409% |
| Veracyte, Inc. | -74.4 Million USD | -715.331% |
| InMed Pharmaceuticals Inc. | -7.67 Million USD | -7803.525% |
| FibroGen, Inc. | -284.23 Million USD | -113.431% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -2212.591% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | -8563.932% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.83 Million USD | -3121.201% |
| Jazz Pharmaceuticals plc | 414.83 Million USD | 246.237% |
| Cyclacel Pharmaceuticals, Inc. | -22.55 Million USD | -2589.599% |
| Amylyx Pharmaceuticals, Inc. | 49.27 Million USD | 1331.229% |
| TG Therapeutics, Inc. | 12.67 Million USD | 4887.24% |
| Galecto, Inc. | -38.34 Million USD | -1481.89% |
| Calithera Biosciences, Inc. | -18.86 Million USD | -3115.515% |
| Fortrea Holdings Inc. | -3.4 Million USD | -17742.324% |
| KalVista Pharmaceuticals, Inc. | -126.64 Million USD | -379.011% |
| Aptevo Therapeutics Inc. | -17.41 Million USD | -3384.228% |
| XBiotech Inc. | -24.55 Million USD | -2370.33% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -841.036% |
| Lyra Therapeutics, Inc. | -62.68 Million USD | -867.835% |
| Foghorn Therapeutics Inc. | -98.42 Million USD | -516.34% |
| Y-mAbs Therapeutics, Inc. | -21.42 Million USD | -2731.19% |
| Theravance Biopharma, Inc. | -55.19 Million USD | -999.123% |
| Metagenomi, Inc. Common Stock | -68.25 Million USD | -788.783% |
| BioCryst Pharmaceuticals, Inc. | -226.53 Million USD | -167.786% |
| Gain Therapeutics, Inc. | -22.26 Million USD | -2624.322% |
| Cartesian Therapeutics, Inc. | -219.71 Million USD | -176.109% |
| NexImmune, Inc. | -32.34 Million USD | -1775.562% |
| Creative Medical Technology Holdings, Inc. | -5.28 Million USD | -11375.088% |
| Marker Therapeutics, Inc. | -14.04 Million USD | -4218.977% |
| Regeneron Pharmaceuticals, Inc. | 3.95 Billion USD | 115.344% |
| Chemomab Therapeutics Ltd. | -24.22 Million USD | -2404.599% |
| RAPT Therapeutics, Inc. | -116.79 Million USD | -419.392% |
| Ainos, Inc. | -13.77 Million USD | -4305.336% |
| Pluri Inc. | -20.88 Million USD | -2804.246% |
| Prothena Corporation plc | -147.02 Million USD | -312.601% |
| Adaptimmune Therapeutics plc | -113.87 Million USD | -432.742% |
| Celularity Inc. | -196.29 Million USD | -209.045% |
| Rallybio Corporation | -74.56 Million USD | -713.582% |
| Cue Biopharma, Inc. | -50.73 Million USD | -1095.748% |
| MeiraGTx Holdings plc | -84.02 Million USD | -621.957% |
| Omeros Corporation | -117.81 Million USD | -414.917% |
| Humacyte, Inc. | -110.77 Million USD | -447.627% |
| Immunocore Holdings plc | -55.28 Million USD | -997.254% |
| Cocrystal Pharma, Inc. | -17.98 Million USD | -3273.215% |
| Cidara Therapeutics, Inc. | -22.93 Million USD | -2545.497% |
| Blueprint Medicines Corporation | -506.98 Million USD | -19.656% |
| CalciMedica, Inc. | -34.35 Million USD | -1665.693% |
| Cabaletta Bio, Inc. | -67.67 Million USD | -796.4% |
| Scholar Rock Holding Corporation | -165.78 Million USD | -265.91% |
| Sana Biotechnology, Inc. | -283.25 Million USD | -114.167% |
| Pulmatrix, Inc. | -14.12 Million USD | -4196.006% |
| Elicio Therapeutics, Inc. | -35.19 Million USD | -1623.651% |
| Vigil Neuroscience, Inc. | -82.63 Million USD | -634.092% |
| Intellia Therapeutics, Inc. | -481.19 Million USD | -26.07% |
| Adlai Nortye Ltd. American Depositary Shares | -104.87 Million USD | -478.462% |
| Cytokinetics, Incorporated | -526.24 Million USD | -15.277% |
| Eloxx Pharmaceuticals, Inc. | -36.06 Million USD | -1582.071% |
| Nutriband Inc. | -5.48 Million USD | -10959.33% |
| Protara Therapeutics, Inc. | -40.42 Million USD | -1400.839% |
| Vor Biopharma Inc. | -117.86 Million USD | -414.698% |
| Roivant Sciences Ltd. | 4.34 Billion USD | 113.949% |
| Evogene Ltd. | -23.87 Million USD | -2440.471% |
| ProKidney Corp. | -35.46 Million USD | -1610.384% |
| Applied Therapeutics, Inc. | -119.76 Million USD | -406.533% |
| Hoth Therapeutics, Inc. | -7.84 Million USD | -7632.426% |
| BridgeBio Pharma, Inc. | -643.2 Million USD | 5.685% |
| CorMedix Inc. | -46.33 Million USD | -1209.126% |
| BioLineRx Ltd. | -60.61 Million USD | -900.823% |
| Tango Therapeutics, Inc. | -101.74 Million USD | -496.241% |
| Galectin Therapeutics Inc. | -41.06 Million USD | -1377.229% |
| Atai Life Sciences N.V. | -40.22 Million USD | -1408.152% |
| Renovaro Biosciences Inc. | -80.65 Million USD | -652.186% |
| Aerovate Therapeutics, Inc. | -75.52 Million USD | -703.272% |
| Zentalis Pharmaceuticals, Inc. | -292.19 Million USD | -107.617% |
| Sagimet Biosciences Inc. | -27.87 Million USD | -2076.205% |
| MediciNova, Inc. | -8.57 Million USD | -6977.383% |
| Praxis Precision Medicines, Inc. | -123.27 Million USD | -392.094% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -7141.865% |
| GeoVax Labs, Inc. | -25.96 Million USD | -2236.214% |
| Axsome Therapeutics, Inc. | -239.23 Million USD | -153.571% |
| Biomea Fusion, Inc. | -117.25 Million USD | -417.367% |
| PTC Therapeutics, Inc. | -626.6 Million USD | 3.186% |
| Mereo BioPharma Group plc | -29.46 Million USD | -1958.776% |
| Cullinan Oncology, Inc. | -153.16 Million USD | -296.077% |
| Absci Corporation | -110.56 Million USD | -448.667% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -1912.07% |
| 4D Molecular Therapeutics, Inc. | -100.83 Million USD | -501.604% |
| Dyne Therapeutics, Inc. | -235.93 Million USD | -157.119% |
| Kiniksa Pharmaceuticals, Ltd. | 14.08 Million USD | 4407.292% |
| Ventyx Biosciences, Inc. | -192.96 Million USD | -214.383% |
| Allakos Inc. | -185.7 Million USD | -226.675% |
| Imunon, Inc. | -19.51 Million USD | -3008.582% |
| Fulcrum Therapeutics, Inc. | -97.33 Million USD | -523.249% |
| Corcept Therapeutics Incorporated | 106.14 Million USD | 671.546% |
| BioAtla, Inc. | -123.46 Million USD | -391.357% |
| NLS Pharmaceutics AG | -12.17 Million USD | -4883.877% |
| Bio-Path Holdings, Inc. | -16.07 Million USD | -3673.1% |
| Allogene Therapeutics, Inc. | -327.26 Million USD | -85.366% |
| Larimar Therapeutics, Inc. | -36.94 Million USD | -1541.828% |
| XOMA Corporation | -40.83 Million USD | -1385.731% |
| Kezar Life Sciences, Inc. | -101.87 Million USD | -495.503% |
| Cara Therapeutics, Inc. | -118.51 Million USD | -411.875% |
| aTyr Pharma, Inc. | -50.38 Million USD | -1103.912% |
| Aligos Therapeutics, Inc. | -87.67 Million USD | -591.886% |
| Akero Therapeutics, Inc. | -151.75 Million USD | -299.738% |
| Viridian Therapeutics, Inc. | -237.73 Million USD | -155.176% |
| Eliem Therapeutics, Inc. | -35.11 Million USD | -1627.381% |
| EyeGate Pharmaceuticals, Inc. | -8.09 Million USD | -7396.83% |
| Akari Therapeutics, Plc | -10 Million USD | -5961.541% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -900960.527% |
| Halozyme Therapeutics, Inc. | 281.59 Million USD | 315.43% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -9001.998% |
| UroGen Pharma Ltd. | -102.24 Million USD | -493.325% |
| Sutro Biopharma, Inc. | -106.79 Million USD | -468.051% |
| ZIVO Bioscience, Inc. | -7.77 Million USD | -7700.24% |
| Orgenesis Inc. | -55.36 Million USD | -995.788% |
| Entera Bio Ltd. | -8.88 Million USD | -6724.603% |
| GH Research PLC | -35.58 Million USD | -1604.665% |
| Lisata Therapeutics, Inc. | -20.84 Million USD | -2810.936% |
| Reneo Pharmaceuticals, Inc. | -77.38 Million USD | -683.893% |
| Xencor, Inc. | -126.08 Million USD | -381.127% |
| 60 Degrees Pharmaceuticals, Inc. | -3.76 Million USD | -16009.586% |
| Replimune Group, Inc. | -215.79 Million USD | -181.119% |
| Coeptis Therapeutics Holdings, Inc. | -21.26 Million USD | -2752.552% |
| Vanda Pharmaceuticals Inc. | 2.5 Million USD | 24278.517% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -9001.998% |
| Portage Biotech Inc. | -75.33 Million USD | -705.212% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -7141.865% |
| Olema Pharmaceuticals, Inc. | -96.65 Million USD | -527.633% |
| OncoCyte Corporation | -27.78 Million USD | -2083.647% |
| Qualigen Therapeutics, Inc. | -13.41 Million USD | -4421.349% |
| Processa Pharmaceuticals, Inc. | -11.12 Million USD | -5354.641% |
| Purple Biotech Ltd. | -19.88 Million USD | -2951.504% |
| CollPlant Biotechnologies Ltd. | -7.01 Million USD | -8542.812% |
| scPharmaceuticals Inc. | -54.81 Million USD | -1006.804% |
| ProMIS Neurosciences, Inc. | -17.5 Million USD | -3365.292% |
| HilleVax, Inc. | -123.56 Million USD | -390.943% |
| NeuroSense Therapeutics Ltd. | -10.1 Million USD | -5902.167% |
| Tharimmune, Inc. | -9.31 Million USD | -6409.635% |
| Genprex, Inc. | -30.86 Million USD | -1865.748% |
| Neumora Therapeutics, Inc. Common Stock | -235.92 Million USD | -157.132% |
| Atossa Therapeutics, Inc. | -30.09 Million USD | -1915.814% |
| XTL Biopharmaceuticals Ltd. | -1.78 Million USD | -33942.593% |
| Virios Therapeutics, Inc. | -5.29 Million USD | -11354.631% |
| OKYO Pharma Limited | -16.82 Thousand USD | -3605382.406% |
| Savara Inc. | -54.69 Million USD | -1009.07% |
| Curis, Inc. | -47.41 Million USD | -1179.478% |
| Daré Bioscience, Inc. | -30.16 Million USD | -1911.31% |
| Carmell Therapeutics Corporation | -15.44 Million USD | -3827.715% |
| Titan Pharmaceuticals, Inc. | -5.56 Million USD | -10793.141% |
| Achieve Life Sciences, Inc. | -29.81 Million USD | -1934.677% |
| BeiGene, Ltd. | -881.7 Million USD | 31.197% |
| Kiromic BioPharma, Inc. | -21.29 Million USD | -2748.873% |
| Revolution Medicines, Inc. Warrant | -436.36 Million USD | -39.02% |
| Protagonist Therapeutics, Inc. | -78.95 Million USD | -668.335% |
| Erasca, Inc. | -125.04 Million USD | -385.148% |
| bluebird bio, Inc. | -211.91 Million USD | -186.268% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -12031.574% |
| BioMarin Pharmaceutical Inc. | 167.64 Million USD | 461.859% |
| DBV Technologies S.A. | -72.72 Million USD | -734.143% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -12031.574% |
| Moderna, Inc. | -4.71 Billion USD | 87.131% |
| Vincerx Pharma, Inc. | -40.15 Million USD | -1410.668% |
| Fresh Tracks Therapeutics, Inc. | -5.69 Million USD | -10554.004% |
| Acrivon Therapeutics, Inc. Common Stock | -60.38 Million USD | -904.569% |
| Travere Therapeutics, Inc. | -111.39 Million USD | -444.564% |
| Monte Rosa Therapeutics, Inc. | -135.35 Million USD | -348.194% |
| Spruce Biosciences, Inc. | -47.91 Million USD | -1165.968% |
| Celldex Therapeutics, Inc. | -141.42 Million USD | -328.935% |
| Cogent Biosciences, Inc. | -192.41 Million USD | -215.285% |
| MacroGenics, Inc. | -9.05 Million USD | -6597.273% |
| RenovoRx, Inc. | -10.23 Million USD | -5828.841% |
| Adicet Bio, Inc. | -142.65 Million USD | -325.24% |
| Prime Medicine, Inc. | -198.13 Million USD | -206.178% |
| Aditxt, Inc. | -32.38 Million USD | -1773.451% |
| Adagene Inc. | -18.94 Million USD | -3101.875% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -8196.8% |
| Quantum-Si incorporated | -95.96 Million USD | -532.179% |
| Maravai LifeSciences Holdings, Inc. | -119.02 Million USD | -409.656% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -4061.398% |
| Voyager Therapeutics, Inc. | 132.33 Million USD | 558.429% |
| SciSparc Ltd. | -5.12 Million USD | -11743.791% |
| Vericel Corporation | -3.18 Million USD | -18964.708% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -504364.716% |
| Minerva Neurosciences, Inc. | -30 Million USD | -1921.769% |
| Generation Bio Co. | -126.61 Million USD | -379.132% |
| Astria Therapeutics, Inc. | -72.89 Million USD | -732.255% |
| Black Diamond Therapeutics, Inc. | -82.44 Million USD | -635.837% |
| Arcutis Biotherapeutics, Inc. | -262.14 Million USD | -131.418% |
| Invivyd, Inc. | -198.64 Million USD | -205.392% |
| Relay Therapeutics, Inc. | -341.97 Million USD | -77.394% |
| Quoin Pharmaceuticals, Ltd. | -8.68 Million USD | -6883.64% |
| Spero Therapeutics, Inc. | 22.8 Million USD | 2759.997% |
| Artelo Biosciences, Inc. | -9.87 Million USD | -6043.802% |
| 2seventy bio, Inc. | -217.57 Million USD | -178.825% |
| ADMA Biologics, Inc. | -28.23 Million USD | -2048.231% |
| Clene Inc. | -49.5 Million USD | -1125.434% |
| Capricor Therapeutics, Inc. | -22.28 Million USD | -2621.875% |
| Boundless Bio, Inc. Common Stock | -49.43 Million USD | -1127.17% |
| GeoVax Labs, Inc. | -25.96 Million USD | -2236.214% |
| Recursion Pharmaceuticals, Inc. | -328.06 Million USD | -84.914% |
| Citius Pharmaceuticals, Inc. | -32.54 Million USD | -1764.12% |
| Contineum Therapeutics, Inc. Class A Common Stock | 22.72 Million USD | 2770.066% |
| Relmada Therapeutics, Inc. | -98.79 Million USD | -514.058% |
| Finch Therapeutics Group, Inc. | -74.75 Million USD | -711.514% |
| ALX Oncology Holdings Inc. | -160.8 Million USD | -277.251% |
| Vir Biotechnology, Inc. | -615.06 Million USD | 1.369% |
| Evaxion Biotech A/S | -22.12 Million USD | -2641.871% |
| Ocular Therapeutix, Inc. | -80.73 Million USD | -651.386% |
| Verve Therapeutics, Inc. | -200.06 Million USD | -203.216% |
| Trevena, Inc. | -40.28 Million USD | -1405.719% |
| Surrozen, Inc. | -43.04 Million USD | -1309.412% |
| Tyra Biosciences, Inc. | -69.13 Million USD | -777.483% |
| Cingulate Inc. | -23.53 Million USD | -2477.609% |
| Galmed Pharmaceuticals Ltd. | -6.91 Million USD | -8676.606% |
| Unity Biotechnology, Inc. | -39.86 Million USD | -1421.924% |
| Tenax Therapeutics, Inc. | -7.71 Million USD | -7767.523% |
| Terns Pharmaceuticals, Inc. | -90.21 Million USD | -572.474% |
| ACADIA Pharmaceuticals Inc. | -61.28 Million USD | -889.849% |
| Connect Biopharma Holdings Limited | -59.5 Million USD | -919.51% |
| Clearmind Medicine Inc. | -11.95 Million USD | -4974.341% |
| Kronos Bio, Inc. | -112.67 Million USD | -438.407% |
| Bolt Biotherapeutics, Inc. | -69.19 Million USD | -776.684% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -23918826.911% |
| Viking Therapeutics, Inc. | -85.89 Million USD | -606.256% |
| Statera Biopharma, Inc. | -174.4 Million USD | -247.827% |
| ImmunityBio, Inc. | -583.19 Million USD | -4.02% |
| Korro Bio, Inc. | -81.17 Million USD | -647.35% |
| Kineta, Inc. | -14.09 Million USD | -4202.709% |
| BioVie Inc. | -32.12 Million USD | -1788.633% |
| Codexis, Inc. | -76.24 Million USD | -695.696% |
| Celularity Inc. | -196.29 Million USD | -209.045% |
| Crinetics Pharmaceuticals, Inc. | -214.52 Million USD | -182.777% |
| Celcuity Inc. | -63.77 Million USD | -851.156% |
| Virax Biolabs Group Limited | -6.73 Million USD | -8909.218% |
| Cibus, Inc. | -267.62 Million USD | -126.673% |
| Eledon Pharmaceuticals, Inc. | -40.32 Million USD | -1404.337% |
| IN8bio, Inc. | -30 Million USD | -1921.658% |
| Kodiak Sciences Inc. | -260.49 Million USD | -132.883% |
| Annexon, Inc. | -134.23 Million USD | -351.916% |
| Adverum Biotechnologies, Inc. | -117.16 Million USD | -417.765% |
| Assembly Biosciences, Inc. | -61.22 Million USD | -890.787% |
| Avalo Therapeutics, Inc. | -31.54 Million USD | -1823.152% |
| Ionis Pharmaceuticals, Inc. | -366.28 Million USD | -65.619% |
| Eyenovia, Inc. | -27.26 Million USD | -2125.292% |
| Puma Biotechnology, Inc. | 21.59 Million USD | 2909.685% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -113290.467% |
| Xilio Therapeutics, Inc. | -76.4 Million USD | -693.989% |
| Arcellx, Inc. | -70.69 Million USD | -758.168% |
| Cardiff Oncology, Inc. | -41.44 Million USD | -1363.862% |
| Enanta Pharmaceuticals, Inc. | -133.81 Million USD | -353.338% |
| Regulus Therapeutics Inc. | -30.03 Million USD | -1919.639% |
| Moolec Science SA | -51.78 Million USD | -1071.369% |
| Acumen Pharmaceuticals, Inc. | -52.37 Million USD | -1058.349% |
| LAVA Therapeutics N.V. | -41.97 Million USD | -1345.273% |
| Royalty Pharma plc | 1.13 Billion USD | 153.456% |
| Atea Pharmaceuticals, Inc. | -135.95 Million USD | -346.202% |
| Greenwich LifeSciences, Inc. | -8.89 Million USD | -6722.452% |
| TFF Pharmaceuticals, Inc. | -21.24 Million USD | -2755.681% |
| Mersana Therapeutics, Inc. | -171.67 Million USD | -253.375% |
| Humacyte, Inc. | -110.77 Million USD | -447.627% |
| 89bio, Inc. | -142.18 Million USD | -326.643% |
| PMV Pharmaceuticals, Inc. | -68.96 Million USD | -779.697% |
| Avenue Therapeutics, Inc. | -10.37 Million USD | -5745.996% |
| Genelux Corporation | -28.29 Million USD | -2043.828% |
| Trevi Therapeutics, Inc. | -29.06 Million USD | -1987.18% |
| Lexicon Pharmaceuticals, Inc. | -177.11 Million USD | -242.504% |
| Notable Labs, Ltd. | -11.26 Million USD | -5285.645% |
| Liquidia Corporation | -78.5 Million USD | -672.769% |
| Mustang Bio, Inc. | -51.6 Million USD | -1075.611% |
| Immunovant, Inc. | -259.33 Million USD | -133.92% |
| Quantum-Si incorporated | -95.96 Million USD | -532.179% |
| Arbutus Biopharma Corporation | -72.84 Million USD | -732.735% |
| DiaMedica Therapeutics Inc. | -19.38 Million USD | -3030.071% |
| Vera Therapeutics, Inc. | -95.99 Million USD | -531.981% |
| Acasti Pharma Inc. | -12.85 Million USD | -4619.824% |
| MiNK Therapeutics, Inc. | -22.45 Million USD | -2601.233% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -3700.601% |
| Xenon Pharmaceuticals Inc. | -182.39 Million USD | -232.6% |
| Elevai Labs, Inc. Common Stock | -4.3 Million USD | -14002.908% |
| NeuroBo Pharmaceuticals, Inc. | -12.47 Million USD | -4764.787% |
| Tempest Therapeutics, Inc. | -29.49 Million USD | -1957.031% |
| Soleno Therapeutics, Inc. | -38.98 Million USD | -1455.963% |
| PepGen Inc. | -78.62 Million USD | -671.55% |
| Moleculin Biotech, Inc. | -29.76 Million USD | -1937.821% |
| United Therapeutics Corporation | 984.8 Million USD | 161.6% |
| Nuvectis Pharma, Inc. | -22.26 Million USD | -2625.243% |
| Solid Biosciences Inc. | -96.01 Million USD | -531.817% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -12560.822% |
| Immuneering Corporation | -53.47 Million USD | -1034.506% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -11825.212% |
| Silo Pharma, Inc. | -3.7 Million USD | -16292.623% |
| Belite Bio, Inc | -31.63 Million USD | -1817.802% |
| XOMA Corporation | -40.83 Million USD | -1385.731% |
| ARS Pharmaceuticals, Inc. | -54.36 Million USD | -1015.863% |
| Bionomics Limited | -15.49 Billion USD | 96.084% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | -622.318% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -1980.595% |
| uniQure N.V. | -308.47 Million USD | -96.656% |
| Cassava Sciences, Inc. | -97.21 Million USD | -524.005% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -8196.8% |
| Poseida Therapeutics, Inc. | -123.43 Million USD | -391.484% |
| Forte Biosciences, Inc. | -31.47 Million USD | -1827.307% |
| Anebulo Pharmaceuticals, Inc. | -8.2 Million USD | -7296.5% |
| Enlivex Therapeutics Ltd. | -29.06 Million USD | -1986.965% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -113290.467% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -2212.591% |
| FibroBiologics, Inc. Common Stock | -16.48 Million USD | -3579.945% |
| Altimmune, Inc. | -88.44 Million USD | -585.879% |
| Amicus Therapeutics, Inc. | -151.58 Million USD | -300.2% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -1980.595% |
| Compugen Ltd. | -18.75 Million USD | -3134.718% |
| Peak Bio, Inc. | -1259.26 USD | -48174145.192% |
| Zevra Therapeutics, Inc. | -46.04 Million USD | -1217.377% |
| Benitec Biopharma Inc. | -21.75 Million USD | -2689.017% |
| Spyre Therapeutics, Inc. | -338.79 Million USD | -79.06% |
| NKGen Biotech, Inc. Common Stock | -82.95 Million USD | -631.296% |
| Zura Bio Limited | -60.36 Million USD | -905.035% |
| PolyPid Ltd. | -23.86 Million USD | -2441.961% |
| Aileron Therapeutics, Inc. | -15.73 Million USD | -3756.083% |
| NKGen Biotech, Inc. Warrants | -82.95 Million USD | -631.296% |
| Instil Bio, Inc. | -156.08 Million USD | -288.654% |
| argenx SE | -295.05 Million USD | -105.603% |
| Immunome, Inc. | -106.8 Million USD | -467.982% |
| Compass Therapeutics, Inc. | -42.49 Million USD | -1327.587% |
| Verona Pharma plc | -54.36 Million USD | -1015.781% |
| enGene Holdings Inc. Warrants | -99.91 Million USD | -507.143% |
| Shattuck Labs, Inc. | -87.29 Million USD | -594.906% |
| CervoMed Inc. | -2.17 Million USD | -27831.606% |
| LENZ Therapeutics, Inc. | -124.65 Million USD | -386.67% |
| Plus Therapeutics, Inc. | -13.31 Million USD | -4455.715% |
| Dianthus Therapeutics, Inc. | -43.55 Million USD | -1292.811% |
| Moolec Science SA | -51.78 Million USD | -1071.369% |
| Enveric Biosciences, Inc. | -17.29 Thousand USD | -3508160.885% |
| Inovio Pharmaceuticals, Inc. | -135.11 Million USD | -348.972% |
| Design Therapeutics, Inc. | -66.86 Million USD | -807.3% |
| Leap Therapeutics, Inc. | -81.41 Million USD | -645.129% |
| NeurAxis, Inc. | -14.62 Million USD | -4047.482% |
| Seelos Therapeutics, Inc. | -37.88 Million USD | -1501.391% |
| Lumos Pharma, Inc. | -34.03 Million USD | -1682.45% |
| Achilles Therapeutics plc | -69.66 Million USD | -770.795% |
| enGene Holdings Inc. Common Stock | -99.91 Million USD | -507.143% |
| 180 Life Sciences Corp. | -19.93 Million USD | -2943.068% |
| Opiant Pharmaceuticals, Inc. | 3 Million USD | 20262.225% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -23918826.911% |
| Nutriband Inc. | -5.48 Million USD | -10959.33% |
| ORIC Pharmaceuticals, Inc. | -100.69 Million USD | -502.44% |
| CG Oncology, Inc. Common stock | -48.6 Million USD | -1148.049% |
| Fractyl Health, Inc. Common Stock | -77.09 Million USD | -686.913% |
| Rani Therapeutics Holdings, Inc. | -33.97 Million USD | -1685.808% |
| MoonLake Immunotherapeutics | -36 Million USD | -1584.769% |
| Palisade Bio, Inc. | -12.3 Million USD | -4832.024% |
| Tourmaline Bio, Inc. | -42.12 Million USD | -1340.127% |
| Beam Therapeutics Inc. | -132.52 Million USD | -357.747% |
| Neurogene Inc. | -36.31 Million USD | -1570.4% |
| Mirum Pharmaceuticals, Inc. | -163.41 Million USD | -271.226% |
| AEON Biopharma, Inc. | -52.55 Million USD | -1054.272% |
| Sesen Bio, Inc. | -19.88 Million USD | -2950.89% |
| Enliven Therapeutics, Inc. | -71.58 Million USD | -747.451% |
| Kiora Pharmaceuticals, Inc. | -12.51 Million USD | -4747.723% |
| Iovance Biotherapeutics, Inc. | -444.03 Million USD | -36.619% |
| Taysha Gene Therapies, Inc. | -111.56 Million USD | -443.749% |
| Athira Pharma, Inc. | -117.67 Million USD | -415.534% |
| Vaccinex, Inc. | -20.25 Million USD | -2895.6% |
| HCW Biologics Inc. | -24.99 Million USD | -2327.112% |
| XOMA Corporation | -40.83 Million USD | -1385.731% |
| Nektar Therapeutics | -276.05 Million USD | -119.752% |
| Arvinas, Inc. | -367.3 Million USD | -65.162% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -900960.527% |
| Merus N.V. | -154.93 Million USD | -291.534% |
| Omega Therapeutics, Inc. | -97.42 Million USD | -522.654% |
| Quince Therapeutics, Inc. | -31.38 Million USD | -1832.895% |
| Rezolute, Inc. | -68.45 Million USD | -786.135% |
| Clene Inc. | -49.5 Million USD | -1125.434% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | -3833.22% |
| BeyondSpring Inc. | -21.02 Million USD | -2785.185% |
| Synlogic, Inc. | -57.28 Million USD | -959.039% |
| Allarity Therapeutics, Inc. | -11.9 Million USD | -4997.378% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -5503.538% |
| Peak Bio, Inc. | -1259.26 USD | -48174145.192% |
| Werewolf Therapeutics, Inc. | -37.36 Million USD | -1523.418% |
| Krystal Biotech, Inc. | 10.93 Million USD | 5649.204% |
| Karyopharm Therapeutics Inc. | -143.09 Million USD | -323.93% |
| SpringWorks Therapeutics, Inc. | -325.1 Million USD | -86.598% |
| Lipella Pharmaceuticals Inc. | -4.61 Million USD | -13033.657% |
| MannKind Corporation | -11.93 Million USD | -4981.58% |
| Ikena Oncology, Inc. | -68.16 Million USD | -789.944% |
| Cyclerion Therapeutics, Inc. | -21.01 Million USD | -2786.695% |
| Gyre Therapeutics, Inc. | -92.93 Million USD | -552.77% |
| Gossamer Bio, Inc. | -179.81 Million USD | -237.365% |
| CohBar, Inc. | -11.96 Million USD | -4971.334% |
| Cognition Therapeutics, Inc. | -25.78 Million USD | -2252.408% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -1912.07% |
| Legend Biotech Corporation | -518.25 Million USD | -17.054% |
| Mural Oncology plc | -207.44 Million USD | -192.431% |
| Biora Therapeutics, Inc. | -124.11 Million USD | -388.772% |
| PaxMedica, Inc. Common Stock | -18.28 Million USD | -3216.83% |
| Disc Medicine, Inc. | -76.42 Million USD | -693.729% |
| Champions Oncology, Inc. | -7.27 Million USD | -8237.534% |
| REGENXBIO Inc. | -263.49 Million USD | -130.229% |
| Ensysce Biosciences, Inc. | -10.61 Million USD | -5615.959% |
| Anavex Life Sciences Corp. | -47.5 Million USD | -1177.0% |
| Cellectar Biosciences, Inc. | -37.98 Million USD | -1497.112% |
| Edgewise Therapeutics, Inc. | -100.16 Million USD | -505.652% |
| Vaxart, Inc. | -82.46 Million USD | -635.632% |
| PharmaCyte Biotech, Inc. | 333.76 Thousand USD | 181857.415% |
| Aldeyra Therapeutics, Inc. | -37.54 Million USD | -1515.872% |
| Cellectis S.A. | -101.05 Million USD | -500.282% |
| Longeveron Inc. | -21.41 Million USD | -2733.041% |
| Repare Therapeutics Inc. | -93.79 Million USD | -546.764% |
| Sarepta Therapeutics, Inc. | -535.97 Million USD | -13.184% |
| Inozyme Pharma, Inc. | -71.16 Million USD | -752.392% |
| Revolution Medicines, Inc. | -436.36 Million USD | -39.02% |
| Nymox Pharmaceutical Corporation | -6.57 Million USD | -9132.065% |
| Third Harmonic Bio, Inc. | -30.82 Million USD | -1868.074% |
| ArriVent BioPharma, Inc. Common Stock | -69.33 Million USD | -774.964% |
| AN2 Therapeutics, Inc. | -64.73 Million USD | -837.155% |
| Anixa Biosciences, Inc. | -9.81 Million USD | -6083.253% |
| Vertex Pharmaceuticals Incorporated | 3.61 Billion USD | 116.76% |
| Denali Therapeutics Inc. | -145.22 Million USD | -317.726% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -504364.716% |
| Veru Inc. | -93.15 Million USD | -551.231% |
| Corvus Pharmaceuticals, Inc. | -27.02 Million USD | -2144.4% |
| Cingulate Inc. | -23.53 Million USD | -2477.609% |
| Passage Bio, Inc. | -102.06 Million USD | -494.383% |
| Context Therapeutics Inc. | -23.96 Million USD | -2431.437% |
| Exicure, Inc. | -16.91 Million USD | -3486.609% |
| Day One Biopharmaceuticals, Inc. | -188.91 Million USD | -221.114% |
| Oramed Pharmaceuticals Inc. | -37.76 Million USD | -1506.395% |
| Scinai Immunotherapeutics Ltd. | -6.5 Million USD | -9222.403% |
| Rhythm Pharmaceuticals, Inc. | -184.67 Million USD | -228.485% |
| Nuvalent, Inc. | -126.21 Million USD | -380.624% |
| ABVC BioPharma, Inc. | -10.51 Million USD | -5668.913% |
| Carisma Therapeutics, Inc. | -86.87 Million USD | -598.257% |
| Unicycive Therapeutics, Inc. | -30.54 Million USD | -1886.115% |
| OmniAb, Inc. | -50.61 Million USD | -1098.441% |
| Anew Medical, Inc. | 1.34 Million USD | 45165.577% |
| Fennec Pharmaceuticals Inc. | -16.04 Million USD | -3680.86% |
| Lipocine Inc. | -16.35 Million USD | -3609.858% |
| Lexeo Therapeutics, Inc. Common Stock | -66.39 Million USD | -813.696% |
| Nautilus Biotechnology, Inc. | -63.67 Million USD | -852.711% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -1337.745% |
| G1 Therapeutics, Inc. | -47.96 Million USD | -1164.701% |
| Bellerophon Therapeutics, Inc. | -19.83 Million USD | -2959.044% |
| Sage Therapeutics, Inc. | -541.48 Million USD | -12.032% |
| Ocugen, Inc. | -63.07 Million USD | -861.728% |
| Mind Medicine (MindMed) Inc. | -95.73 Million USD | -533.685% |
| Q32 Bio Inc. | -112.96 Million USD | -437.034% |
| Brainstorm Cell Therapeutics Inc. | -17.19 Million USD | -3428.612% |
| Alumis Inc. Common Stock | -154.99 Million USD | -291.398% |
| Equillium, Inc. | -13.33 Million USD | -4449.224% |
| Kyverna Therapeutics, Inc. | -60.36 Million USD | -904.935% |
| Coya Therapeutics, Inc. | -7.98 Million USD | -7494.535% |
| CNS Pharmaceuticals, Inc. | -18.85 Million USD | -3118.035% |
| Galera Therapeutics, Inc. | -59.08 Million USD | -926.775% |
| Evelo Biosciences, Inc. | -114.52 Million USD | -429.691% |
| Comera Life Sciences Holdings, Inc. | -18.37 Million USD | -3200.906% |
| Dominari Holdings Inc. | -22.88 Million USD | -2551.162% |
| Edesa Biotech, Inc. | -8.37 Million USD | -7143.957% |
| vTv Therapeutics Inc. | -20.25 Million USD | -2895.748% |
| Bio-Techne Corporation | 168.1 Million USD | 460.869% |
| Agios Pharmaceuticals, Inc. | -352.08 Million USD | -72.298% |
| Harmony Biosciences Holdings, Inc. | 128.85 Million USD | 570.799% |
| Prelude Therapeutics Incorporated | -121.83 Million USD | -397.931% |
| Candel Therapeutics, Inc. | -37.93 Million USD | -1498.985% |
| iTeos Therapeutics, Inc. | -112.64 Million USD | -438.555% |
| Nkarta, Inc. | -117.5 Million USD | -416.284% |
| BioCardia, Inc. | -11.57 Million USD | -5142.753% |
| Iterum Therapeutics plc | -38.37 Million USD | -1480.983% |